Yes I still feel their is strong growth in GSS as well ( still...

Yes I still feel their is strong growth in GSS as well ( still holding ) but I can see AHZ and OSL both giving a better return . AHZ will go gang busters after the initial TAVR human implant and I suspect WP already has some sort of preliminary deal on the table subject to the results of the trials . The ADAPT TAVR if successful in human trials has the potential to dominate and increase the TAVR market space . Realistically younger patients will not have to go through open heart surgery like they currently do now if the longevity of ADAPT TAVR stacks up to the hype . If your interested in AHZ Silva I suggest you buy sooner rather than latter because this TAVR trial might be sooner than we all think , who knows ?